Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Cash on Hand 2014–2025
Akebia Therapeutics Inc. annual cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Akebia Therapeutics Inc. cash on hand as of December 31, 2025: 184.8M, a 256.36% increase year-over-year.
- Akebia Therapeutics Inc. cash on hand for 2025 were 184.8M, a 256.36% increase from 2024.
- Akebia Therapeutics Inc. cash on hand for 2024 were 51.9M, a 20.84% increase from 2023.
- Akebia Therapeutics Inc. cash on hand for 2023 were 42.9M, a 52.55% decrease from 2022.
- Akebia Therapeutics Inc. cash on hand for 2022 were 90.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Akebia Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $185 |
| 2024 | $52 |
| 2023 | $43 |
| 2022 | $90 |
| 2021 | $150 |
| 2020 | $229 |
| 2019 | $147 |
| 2018 | $105 |
| 2017 | $70 |
| 2016 | $187 |
| 2015 | $50 |
| 2014 | $33 |
Akebia Therapeutics Inc. Cash on Hand — FAQ
Akebia Therapeutics Inc. (AKBA) cash on hand over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AKBA's cash on hand history?
The chart and table above show Akebia Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.